+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06328361

Nordic Organ Preservation Approach for Nonoperative Management of Rectal Cancer with Complete Clinical Response

Led by Tampere University Hospital · Updated on 2026-09-30

200

Participants Needed

13

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying nonoperative management NOM for patients with rectal cancer who achieve a complete clinical response after neoadjuvant therapy. This single-arm, international trial aims to establish a unified NOM protocol and evaluate oncological outcomes, such as organ preservation and local regrowth rates, in Finnish and Estonian treatment settings compared to global experiences. Participants with confirmed complete clinical response will receive nonoperative surveillance including clinical examinations, rectal MRI, endoscopy, and body CT scans. The study involves close monitoring every 3 months during the first 2 years and every 6 months thereafter up to 5 years. No randomization is involved, and treatment aligns with Nordic practice standards. During the trial, participants will undergo regular clinical and imaging assessments to monitor for local regrowth or distant spread. Researchers will measure disease-free survival at 2 years as the primary outcome, alongside secondary outcomes such as overall survival, quality of life, and complication rates up to 5 years. Data will be securely collected and monitored as part of standard care, with safety procedures in place for local recurrence events.

CONDITIONS

Brief Title

Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer

Research Team

T

Toni T Seppälä, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here